{"id":"W4240080893","doi":"10.1200/jco.2012.30.18_suppl.lba10008","title":"Randomized phase III trial of regorafenib in patients (pts) with metastatic and/or unresectable gastrointestinal stromal tumor (GIST) progressing despite prior treatment with at least imatinib (IM) and sunitinib (SU): GRID trial.","year":2012,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Gastrointestinal Tumor Research and Treatment","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"ca_institutions":"Mount Sinai Hospital","funders":"","keywords":"Medicine; Regorafenib; Internal medicine; Clinical endpoint; Hazard ratio; GiST; Randomization; Randomized controlled trial; Placebo; Gastroenterology; Surgery; Confidence interval; Cancer; Colorectal cancer; Pathology; Stromal cell","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004933238,0.0003801943,0.003707174,0.0003008073,0.00009974566,0.00003246877,0.0001049964,0.00006095922,0.00007887057],"category_scores_gemma":[0.005502315,0.0001889899,0.0003096831,0.0002205242,0.001069961,0.0002748109,0.00007668346,0.0006572316,0.000001525437],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003562551,"about_ca_system_score_gemma":0.001790474,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00007255264,"about_ca_topic_score_gemma":0.00009479978,"domain_scores_codex":[0.9935546,0.001655495,0.002985592,0.0003205225,0.0007777635,0.000706047],"domain_scores_gemma":[0.9901304,0.004949362,0.003089268,0.0002215837,0.000558758,0.001050636],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8746039,0.02071396,0.08508722,0.00009984039,0.0005384664,0.002223191,0.0001185864,0.000001869258,0.00003223944,0.00001073233,0.00002084164,0.01654917],"study_design_scores_gemma":[0.6924725,0.2918504,0.008482879,0.0008264293,0.001086145,0.004743316,0.0001867529,0.00008397222,0.00006562194,0.000006907392,0.00009469498,0.0001003463],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9951425,0.0002556263,0.00008769651,0.0004822058,0.0001296511,0.003718304,0.00001874853,0.000009297709,0.0001559696],"genre_scores_gemma":[0.960988,0.0000630573,0.0382336,0.00003961203,0.0004065206,0.00009338056,0.0000175651,0.00003483318,0.0001233963],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2711365,"threshold_uncertainty_score":0.7706786,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1390128879229256,"score_gpt":0.4586018462701245,"score_spread":0.3195889583471989,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}